» Articles » PMID: 36771109

Microorganisms for Ginsenosides Biosynthesis: Recent Progress, Challenges, and Perspectives

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Feb 11
PMID 36771109
Authors
Affiliations
Soon will be listed here.
Abstract

Ginsenosides are major bioactive compounds present in the species. Ginsenosides exhibit various pharmaceutical properties, including anticancer, anti-inflammatory, antimetastatic, hypertension, and neurodegenerative disorder activities. Although several commercial products have been presented on the market, most of the current chemical processes have an unfriendly environment and a high cost of downstream processing. Compared to plant extraction, microbial production exhibits high efficiency, high selectivity, and saves time for the manufacturing of industrial products. To reach the full potential of the pharmaceutical resource of ginsenoside, a suitable microorganism has been developed as a novel approach. In this review, cell biological mechanisms in anticancer activities and the present state of research on the production of ginsenosides are summarized. Microbial hosts, including native endophytes and engineered microbes, have been used as novel and promising approaches. Furthermore, the present challenges and perspectives of using microbial hosts to produce ginsenosides have been discussed.

Citing Articles

Phytochemistry, quality control and biosynthesis in ginseng research from 2021 to 2023: A state-of-the-art review concerning advances and challenges.

Ding M, Cheng H, Li X, Li X, Zhang M, Cui D Chin Herb Med. 2024; 16(4):505-520.

PMID: 39606254 PMC: 11589329. DOI: 10.1016/j.chmed.2024.08.002.


Identify Regioselective Residues of Ginsenoside Hydrolases by Graph-Based Active Learning from Molecular Dynamics.

Li Y, Peng H, Wen M, Yang L Molecules. 2024; 29(15).

PMID: 39125019 PMC: 11314057. DOI: 10.3390/molecules29153614.


Advances in Engineering Nucleotide Sugar Metabolism for Natural Product Glycosylation in .

Crowe S, Liu Y, Zhao X, Scheller H, Keasling J ACS Synth Biol. 2024; 13(6):1589-1599.

PMID: 38820348 PMC: 11197093. DOI: 10.1021/acssynbio.3c00737.


Endophytic fungi of Panax sokpayensis produce bioactive ginsenoside Compound K in flask fermentation.

Rai S, Singh L, Shaanker R, Jeyaram K, Parija T, Sahoo D Sci Rep. 2024; 14(1):9318.

PMID: 38654024 PMC: 11039684. DOI: 10.1038/s41598-024-56441-3.


Biotransformation approach to produce rare ginsenosides F1, compound Mc1, and Rd2 from major ginsenosides.

Diao M, Chen Y, Meng L, Li J, Xie N Arch Microbiol. 2024; 206(4):176.

PMID: 38493413 DOI: 10.1007/s00203-024-03893-w.


References
1.
Yan H, Jin H, Fu Y, Yin Z, Yin C . Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from . J Agric Food Chem. 2019; 67(31):8493-8499. DOI: 10.1021/acs.jafc.9b03159. View

2.
Kwon H, Lee H, Choi G, Kwon S, Song A, Kim S . Ginsenoside F1 Promotes Cytotoxic Activity of NK Cells via Insulin-Like Growth Factor-1-Dependent Mechanism. Front Immunol. 2018; 9:2785. PMC: 6279892. DOI: 10.3389/fimmu.2018.02785. View

3.
Shen W, Wei Y, Tang D, Jia X, Chen B . Metabolite profiles of ginsenosides Rk1 and Rg5 in zebrafish using ultraperformance liquid chromatography/quadrupole-time-of-flight MS. J Ginseng Res. 2017; 41(1):78-84. PMC: 5223078. DOI: 10.1016/j.jgr.2015.12.010. View

4.
Luo Y, Jiang Y, Chen L, Li C, Wang Y . Applications of protein engineering in the microbial synthesis of plant triterpenoids. Synth Syst Biotechnol. 2022; 8(1):20-32. PMC: 9634032. DOI: 10.1016/j.synbio.2022.10.001. View

5.
Nag S, Qin J, Wang W, Wang M, Wang H, Zhang R . Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action. Front Pharmacol. 2012; 3:25. PMC: 3289390. DOI: 10.3389/fphar.2012.00025. View